Gather-ed - Advanced Endometrial Cancer in the Immunotherapy Age

Time Commitment:	4 hours over 56 days
Target Professions:	DO, MD, Nurse, Nurse Practitioner, Physician Assistant
Target Specialties:	Family Medicine, Internal Medicine, Hematology, Hematology/Oncology, Oncology, Women's Health, Gynecologic Oncology, Gynecologic Oncology
Credits Available:	4.0 AMA PRA Category 1 Credit™

Endometrial cancer is among the few cancers increasing in incidence and mortality in the United State and remains the most common gynecologic cancer diagnosed. To improve clinical outcomes, clinicians treating patients with endometrial cancer need to understand the molecular classification of the disease, the newest guidelines on management, and the evidence underlying these recommendations.

Along with this, clinicians must be aware of the most effective ways to manage possible adverse events as well as be cognizant of how best to address racial disparities in care. This educational initiative will allow clinicians to learn and discuss these crucial points in diagnosing and managing these patients to increase long-term survival.

Given the rapid shift in best practices occurring in this area and the fact that current NCCN Guidelines classify endometrial cancers into 1 of 4 molecular groups, as opposed to the traditional 2 groups, it is important for clinicians to stay up to date as advances in areas such as biomarker research continue to be made.

This educational activity allows clinicians to engage in interprofessional discussions with knowledgeable experts and peers to more fully understand how to integrate these new treatment approaches into their day-to-day practice and establish actionable plans to improve outcomes for their patients.

CME/CE Accreditation Information

Self Study

Advanced Endometrial Cancer in the Immunotherapy Age - Baseline Assessment

The following questions are designed to assess your knowledge and practice of patients with endometrial cancer.
Module 1: Emerging Use of Molecular Classification in Endometrial Cancer

This module will discuss the emerging use of molecular classification in endometrial cancer (EC).
Module 2: Key Clinical Trials in Endometrial Cancer

This module will discuss key clinical trials in endometrial cancer. The emphasis will be on advanced, metastatic, recurrent endometrial cancer.
Module 3: Interpretation of Molecular Classification in Endometrial Cancer Treatment

This module will discuss three endometrial cancer cases to cover the interpretation of molecular classification as it applies to endometrial cancer treatment.
Module 4: Recognition and Management of Immune-Related Adverse Events Associated with Endometrial Cancer Treatment

This module will discuss the recognition and management of immune-related adverse events (irAEs) associated with endometrial cancer treatment.
Advanced Endometrial Cancer in the Immunotherapy Age - Final Assessment

The following questions are designed to assess your gained knowledge and practice of patients with endometrial cancer.

Live Group Discussions

Key Insights on Endometrial Cancer and Take-Home Messages: Putting the Evidence to Practice

During this discussion, we will review the modules and approaches to treatment that offer optimal care to patients with endometrial cancer
Patient Case Review: Discussing Treatment and Care for Patients with Endometrial Cancer

During this discussion, we will review the patient case and discuss treatment plans. Additionally, we will share our action plans and how this CME activity will shape our practice regarding patient care.

Group Tasks

Endometrial Cancer: Pamela's Case

This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.
Endometrial Cancer: Pamela's Case Continued

This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.

My Action Plans

Your action plan - Endometrial Cancer

In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the outcomes for your patients with endometrial cancer.

Curriculum is Currently Closed

Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.

View Other Offerings